Supplemental material
Current Medical Research and Opinion
Volume 39, 2023 - Issue 4
Diabetes
Admission eGFR predicts in-hospital mortality independently of admission glycemia and C-peptide in patients with type 2 diabetes mellitus and COVID-19
Marco Infantea Department of Systems Medicine & Diabetes Research Institute Federation (DRIF), University of Rome Tor Vergata, Rome, Italy;b Section of Diabetes and Metabolic Disorders, UniCamillus, Saint Camillus International University of Health Sciences, Rome, Italy;c Cell Transplant Center, Diabetes Research Institute (DRI), University of Miami Miller School of Medicine, Miami, FL, USACorrespondence[email protected] [email protected]
https://orcid.org/0000-0003-2032-8735
https://orcid.org/0000-0003-2032-8735, Massimo Pierid Department of Experimental Medicine, Clinical Biochemistry and Molecular Biology, Faculty of Medicine, University of Rome Tor Vergata, Rome, Italy;e Clinical Biochemistry Department, Tor Vergata University Hospital (PTV), Rome, Italyhttps://orcid.org/0000-0002-3463-0268
https://orcid.org/0000-0002-3463-0268, Santina Lupisellae Clinical Biochemistry Department, Tor Vergata University Hospital (PTV), Rome, Italyhttps://orcid.org/0000-0001-6355-6987
https://orcid.org/0000-0001-6355-6987, Ali Mohamade Clinical Biochemistry Department, Tor Vergata University Hospital (PTV), Rome, Italyhttps://orcid.org/0000-0001-7169-4247
https://orcid.org/0000-0001-7169-4247, Sergio Bernardinid Department of Experimental Medicine, Clinical Biochemistry and Molecular Biology, Faculty of Medicine, University of Rome Tor Vergata, Rome, Italy;e Clinical Biochemistry Department, Tor Vergata University Hospital (PTV), Rome, Italyhttps://orcid.org/0000-0003-1984-6834
https://orcid.org/0000-0003-1984-6834, David Della-Mortef Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italyhttps://orcid.org/0000-0002-4054-5318
https://orcid.org/0000-0002-4054-5318, Andrea Fabbria Department of Systems Medicine & Diabetes Research Institute Federation (DRIF), University of Rome Tor Vergata, Rome, Italyhttps://orcid.org/0000-0003-2269-1554
https://orcid.org/0000-0003-2269-1554, Alberto De Stefanog Psychiatry Unit, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy;h Volunteers Association, Tor Vergata University Hospital (PTV), Rome, Italyhttps://orcid.org/0000-0001-7947-6586
https://orcid.org/0000-0001-7947-6586, Marco Iannettaf Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy;i Infectious Disease Clinic, Tor Vergata University Hospital (PTV), Rome, Italyhttps://orcid.org/0000-0002-6938-8627
https://orcid.org/0000-0002-6938-8627, Lorenzo Ansaldof Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy;i Infectious Disease Clinic, Tor Vergata University Hospital (PTV), Rome, Italyhttps://orcid.org/0000-0003-1597-3393
https://orcid.org/0000-0003-1597-3393, Angela Creaf Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy;i Infectious Disease Clinic, Tor Vergata University Hospital (PTV), Rome, Italyhttps://orcid.org/0000-0002-4978-7057
https://orcid.org/0000-0002-4978-7057, Massimo Andreonif Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy;i Infectious Disease Clinic, Tor Vergata University Hospital (PTV), Rome, Italyhttps://orcid.org/0000-0002-3205-9758
https://orcid.org/0000-0002-3205-9758 & Maria Morellod Department of Experimental Medicine, Clinical Biochemistry and Molecular Biology, Faculty of Medicine, University of Rome Tor Vergata, Rome, Italy;e Clinical Biochemistry Department, Tor Vergata University Hospital (PTV), Rome, ItalyCorrespondence[email protected]
https://orcid.org/0000-0002-9023-1106
https://orcid.org/0000-0002-9023-1106 show all